NEUROLOGICALSEQUELAE of DIABETESHYPERTENSION “NEUROLOGICAL SEQUELAE of DIABETES & HYPERTENSION ” 1 Patrick A. GRIFFITH, MD, FAAN Professor Clinical Medicine.

Slides:



Advertisements
Similar presentations
The Memory Assessment and Treatment Service (MATS)
Advertisements

Vascular cognitive impairment – an overview
 Most common and important degenerative disease of the brain  Shrinkage in size and weight of the brain  Severe degree of diffuse cerebral atrophy.
APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
Circulación Cerebral y Demencia Senil. Interactions between VaD and AD VaD post-stroke dementia infarcts, white matter lesions (WMLs) vascular risk factors.
Frontotemporal Dementia
Martha Stearn, MD Institute for Cognitive Health St John’s Medical Center Jackson, Wyoming.
J. Stephen Huff, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
Dementia with Lewy Bodies
Mild Cognitive Impairment
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
GAL-INT-6 The safety and efficacy of galantamine in patients with Vascular dementia or AD with cerebrovascular disease Sean Lilienfeld MD, FCP, MMed Janssen.
How Alzheimer’s Disease Differs from Frontal Temporal Lobe Dementia (Pick’s Disease) Josepha A. Cheong, MD University of Florida Departments of Psychiatry.
Small Vessel Diseases of the Brain
Subtype of VaD: SIVD Subcortical Ischemic Vascular Disease Helena Chui, M.D. University of Southern California Rancho Los Amigos National Rehabilitation.
Case Study 63 Kenneth Clark, MD.
Screening for Stroke and Cognitive Impairment Chapter 2: Background.
Alzheimer’s Disease and Biomarkers John H. Dougherty,Jr.M.D. Medical Director Cole Neuroscience Center.
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
VASCULAR DEMENTIA (VaD) A BRIEF REVIEW WITH SPECIAL EMPHASIS ON CURRENT CLINICAL IMPACT MURRAY FLASTER MD, PhD BARROW NEUROLOGICAL CLINIC.
Chapter 15 - Cognitive Disorders I.Delirium Acute, temporary impairment in perception & cognition Fluctuating course.
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
ALZHEIMER’S PART 2. AD VIDEO
Dementia in Clinical Practice Mary Ann Forciea MD Clinical Prof of Medicine Division of Geriatric Medicine UPHS Photo: Nat Geographic.
Dementia Dr Deborah Stinson Sutton CMHT for Older People
Alzheimer’s Disease Landscape
Non-Alzheimer’s Dementias
How To Improve Memory Performance and Keep Your Brain Young Gary W. Small, MD Parlow-Solomon Professor on Aging Professor of Psychiatry & Biobehavioral.
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
THE COGNITIVE DISORDERS Brian E. Wood, D.O. Associate Professor and Chair Department of Neuropsychiatry and Behavioral Sciences Edward Via Virginia College.
Parkinson’s Plus By: Glen Estrosos.
Jack Twersky, MD Medical Director CLC Durham.  Memory impairment and at least one of the following  Aphasia  Apraxia  Agnosia  Executive function.
Why Physicians Do Not Diagnose Alzheimer’s Disease Mark A. Sager, MD Professor of Medicine and Population Health Sciences Director, Wisconsin Alzheimer’s.
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
HOW TO EXAMINE PATIENTS WITH DEMENTIA Serge Gauthier, MD, FRCPC McGill Centre for Studies in Aging Douglas Mental Health Research Institute.
The Dementias Dr Giles Richards Consultant Psychiatrist CFT.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting - March 14, Issues Related to the Development of Drugs for the Treatment.
CAROLINE HARADA, M.D. ASSOCIATE PROFESSOR OF MEDICINE UAB DIVISION OF GERONTOLOGY, GERIATRICS, AND PALLIATIVE CARE NOVEMBER 2013 Dementia.
Dementia in Clinical Practice Mary Ann Forciea MD Clinical Prof of Medicine Division of Geriatric Medicine UPHS Photo: Nat Geographic.
Alabama Brief Cognitive Screener (ABCs)
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
Background. Vascular Cognitive Impairment Vascular Cognitive Impairment (VCI) includes the cognitive and behavioural disorders associated with cerebrovascular.
Alzheimer’s Disease Today and Tomorrow First case reported in 1906 Reported by Alois Alzheimer Patient Augusta D. first treated at 46 years old Paranoia,
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Used to be called Dementia Neurocognitive Disorders.
Comparison of Risk Factors for Early-Onset versus Late-Onset Alzheimer Disease OBJECTIVE To compare early-onset (before 65) Alzheimer disease (AD) patients.
Sint Lucas-Andreas Hospital, Amsterdam
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
Chapter 14 Neurocognitive Disorders
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
Teaching NeuroImages Neurology Resident and Fellow Section © 2014 American Academy of Neurology MRI-visible Virchow-Robin Perivascular Spaces in Cerebral.
Dementia F.Etessam. MD. Dementia A progressive impairment of cognitive functions occurring in clear consciousness.
DEMENTIA 1/6/16 DR TONY O’BRIEN MD FRCP. Dementia Common – 700,000 sufferers in the UK Common – 700,000 sufferers in the UK Prevalence increases with.
Dementia Jaqueline Raetz, M.D.. Types of Dementia Alzheimer Dementia 70% Lewy Body Dementia about 22% Vascular Dementia 17% Frontotemporal Dementia Overall.
M. M. Dumitru¹∙², V.Chirita¹∙², R.Chirita¹∙²
The Malfunctioning Mind: Degenerative Diseases of the Brain
Dementia Jaqueline Raetz, M.D..
In collaboration with:
Dementia Jaqueline Raetz, M.D..
Poststroke dementia Vikas Dhikav,
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) and Review of Literature Zebin Xiao Department of.
Cognitive Disorders and Aging
Chapter 30 Delirium and Dementia
Chapter 93 Dementias and Related Disorders
The Memory Assessment and Treatment Service (MATS)
Chapter 25 The Elderly.
Ongoing Research With Vascular Risk Factors and the RAS in Individuals at Risk for AD Whitney Wharton, PhD Assistant Professor,
Presentation transcript:

NEUROLOGICALSEQUELAE of DIABETESHYPERTENSION “NEUROLOGICAL SEQUELAE of DIABETES & HYPERTENSION ” 1 Patrick A. GRIFFITH, MD, FAAN Professor Clinical Medicine (Retired). Former Professor of Neurology and Medical Director of the Clinical Research Center at Meharry Medical College in Nashville, Tennessee.

Disclosure Statement Patrick A. Griffith, MD, FAAN : Speakers’ Bureaus  Sunovion NIH Study Sections: A.N.I.E.  N.I.N.R.  Consultant/Advisory Board  Duke University, Bryan ADRC.  Emory University, ADRC Honoraria Wayne State University NMA, FM section. University of Wisconsin, SOM, Madison. Norman Seay Foundation, Knight ADRC, Washington Univ.,St.Louis, MO. MIMA Conference, Columbia,Missouri,” STAYING SHARP” lectures :Dana Foundation,” STAYING SHARP” lectures : Gainesville, GA. Grant/Research Support 0 2

3 NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION :

4

5

NEUROLOGICAL SEQUELAE of DIABETES : 6

7 NEUROLOGICAL SEQUELAE of DIABETES:

NEUROLOGICAL SEQUELAE of DIABETES : 8

9

10

11

NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION : 12

13 NEUROLOGICAL SEQUELAE NEUROLOGICAL SEQUELAE of DIABETES & HYPERTENSION

14 NEUROLOGICAL SEQUELAE NEUROLOGICAL SEQUELAE of DIABETES & HYPERTENSION

15 NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION :

16 NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION :

17

18

Willis Dementia Occurring Post-apoplexy Binswanger, Alzheimer Arteriosclerotic Dementia, SAE Kraepelin Arteriosclerotic Dementia DSM-I Chronic Brain Syndrome Hachinski Scale Roman Lacunar Dementia Erkinjuntti Cortical vs. Subcortical NINDS- AIREN Criteria DSM-IV Executive Dysfunction Katzman AD is the Main Cause of Atrophy and Dementia DSM-III MID NINDS- ADRDA Criteria for AD VaD AD VaD DEMENTIADEMENTIA Pathological Reports of Alzheimer’s disease (AD) CADASIL First Genetic Form of VaD VASCULAR DEMENTIA[VaD]: An historical perspective – Salloway, S. 03/

20

NEUROLOGICAL SEQUELAE of HYPERTENSION : 21

NEUROLOGICAL SEQUELAE of HYPERTENSION : 22

NEUROLOGICAL SEQUELAE of DIABETES & HYPERTENSION 23

Genes Vascular Risk Factors Capillary Brain Injury Symptoms/Signs Large ArteryMajor Infarct STROKE ArterioleLacune WML Stroke or “Silent” Stroke LDL-C Homo Cysteine CAA HTN DM ApoE4 FAD CapillaryMicroinfarctOther Behavior Other Genes:*** ACE (D/D) NO Synthase Prorenin Chui, H. C. April, NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION :

NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION 25 Abrupt “Stepwise” PresentPresentPresentCADASIL “Spotty deficits” Executive dysfunction often prominent “Spotty deficits” Executive dysfunction often prominentInsidious Slow, gradual Usually absent May be present Present Memory, naming  with typical progression OnsetProgression Focal neurologic signs or symptoms Vascular Risk Factors (eg, HTN, DM, TIA/CVA, CAD ) Genetics Cognitive profile VASCULAR DEMENTIA AD

26 NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION :

NEUROLOGICAL SEQUELAE of DIABETES & HYPERTENSION : 1.Clues to a NON-Alzheimer's Etiology for Dementia Youth Sleepiness or reduced state of alertness History of STROKE Prominent headache Rapid course Fever 27 Ethnicity & Disease, 2002, Volume 12(1) s s2-27 Caplan, L. 1976

NEUROLOGICAL SEQUELAE of DIABETES & HYPERTENSION : 2.Clues to a NON-Alzheimer‘s Etiology for Dementia Seizures Prominent early motor, reflex, or visual abnormalities Focal neurological signs Abnormal gait History of STROKE 28 Ethnicity & Disease, 2002, Volume 12(1) s s2-27 Caplan, L. 1976

Type of Dementia by Ethnicity (percentage of cases in Ethnic group) Note: p <.001; N = 4,875. For 271 (6%), the diagnosis was another type of Dementia; for 325 (7%), Amnestic Syndromes; and for 244 (5%), the diagnosis was deferred. Yeo, et al; in Ethnicity and Dementia, Taylor & Francis Eds, 1996,pp Types of DEMENTIA by Ethnicity : 29

30 p.188: Karger,Basel “Stroke in Blacks” “Stroke in Blacks” Eds.: Gillum, RF Gorelick, PB & Cooper, ES. NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION :

Non-modifiable VaD risk factors Age Race Gender Genetics Gorelick PB, Griffith P. In: Gillum RF, Gorelick PB, Cooper ES, eds. Stroke in Blacks. Basel: Karger; 1999:

32

VASCULAR DEMENTIA: Risk Factors Gorelick & Nyenhuis 1998 DEMOGRAPHIC Age Male sex RACE/Ethnicity (e.g. Asians, African-Americans ?Caribbean-Africans ? Caribbean Hispanics) Lower educational level Stroke 2004;35[Suppl 1]: GENETIC  CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY with SUBCORTICAL INFARCTS and LEUCOENCEPHALOPATHY [C.A.D.A.S.I.L.]  ApoE : e4 allele 33

NEUROLOGICAL COMPLICATIONS of DIABETES & HYPERTENSION Vascular Dementia Clinical Profile: Older more Men Higher HACHINSKI Score More CV diagnoses More CV medications More Cerebro-Vascular Disease on Imaging 34 Salloway,S.- Neurology 2003;60:A141-A142.

NEUROLOGICAL SEQUELAE NEUROLOGICAL SEQUELAE of DIABETES & HYPERTENSION : 35

36 NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION :

37 NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION :

38 NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION :

39 NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION

NEUROLOGICAL COMPLICATIONS of DIABETES & HYPERTENSION 40

41 NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION :NEUROLOGICAL SEQUELAE of DIABETES & HYPERTENSION

42 NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION :

43

the NEUROLOGICAL SEQUELAE DIABETES & HYPERTENSION: LEARNING Objectives : After attending this lecture, participants will know - How to Diagnose & Treat the NEUROLOGICAL SEQUELAE of DIABETES & HYPERTENSION: 44

45 NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION :

46 NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION :

47

48

NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION : 49

50 St. LOUIS UNIVERSITY SCHOOL of MEDICINE, St. Louis,MO,USA

VASCULAR DEMENTIA [VaD] NEUROLOGICAL SEQUELAE of DIABETES & HYPERTENSION = VASCULAR DEMENTIA [VaD] An Historical Perspective; Salloway,S Willis Dementia Occurring Post-apoplexy Binswanger, Alzheimer Arteriosclerotic Dementia, SAE Kraepelin Arteriosclerotic Dementia DSM-I Chronic Brain Syndrome Hachinski Scale Roman Lacunar Dementia Erkinjuntti Cortical vs. Subcortical NINDS- AIREN Criteria DSM-IV Executive Dysfunction Katzman AD is the Main Cause of Atrophy and Dementia DSM-III MID NINDS- ADRDA Criteria for AD VaD AD VaD DEMENTIADEMENTIA Pathological Reports of Alzheimer’s disease (AD) CADASIL First Genetic Form of VaD

NINDS-AIREN criteria for VaD Developed for use in clinical trials Evidence for CEREBRO-VASCULAR DISEASE[CVD] from neurologic examination & neuro-imaging Impaired memory plus two other cognitive domains Temporal relationship between Dementia & CVD – Probable VaD – Possible VaD Roman GC, et al. Neurology. 1993;43:

VASCULAR DEMENTIA Clinical Differences Between VASCULAR DEMENTIA & AD : 53 NEUROLOGICAL SEQUELAE of DIABETES &HYPERTENSION :

54

Two Extremes of VaD and AD Description Pure AD Plaque only AD AD with Severe CAA CAA with Plaques AD with Vascular Lesions AD with Cerebrovascular Disease VaD with AD changes VaD with AD changes VaD with Small-vessel Disease VaD with Small-vessel Disease Pure VaD Pure VaD Identifying Features Plaque with Neurofibrillary Pathology Only Lack of Neurofibrillary Pathology Profound Vascular Amyloid Deposition Mild AD with Vascular Involvement Vascular Lesions include Microinfarcts Mixed Dementia Mixed Dementia or Coincidental AD Pathology Prominent Micro-vascular Changes Infraction only and White Matter Lesions R Kalaria/Journal of Nerological Sciences (2002)

NEUROLOGICAL SEQUELAE of DIABETES & HYPERTENSION: 56 VASCULAR DEMENTIA[VaD] = 15% patients SECOND VaD is the SECOND most common form of Dementia in the elderly VaD Incidence increases with age Primary Care Physicians[PCPs] are the main gatekeepers. VaD is an unsatisfied market DLB DLB=dementia with Lewy bodies.  Small GW, et al. JAMA. 1997;278:  Morris JC. Clin Geriatr Med. 1994;10: Alzheimer’s disease (AD) 65% VaD VaD and AD 5% DLB and Parkinson’s Other dementias 8% 7% AD and DLB 10% 5%

NEUROLOGICAL SEQUELAE of DIABETES & HYPERTENSION 57 Mild Cognitive Impairment [MCI] Alzheimer’s disease VASCULAR Dementia VASCULAR Dementia Dementia with Lewy bodies Traditional dementia concept Other dementia VASCULAR Dementia Other dementia Dementia with Lewy bodies Alzheimer’s disease The emerging consensus Salloway,S.- Neurology 2003;60:A141-A142.

…” I tell you,when you were YOUNGER, you used to fasten your own belt and to go wherever you wished. But when you grow OLD, you will stretch out your hands, and someone else will fasten a belt around you and take you where you did NOT wish to go NEUROLOGICAL SEQUELAE of DIABETES & HYPERTENSION …” I tell you,when you were YOUNGER, you used to fasten your own belt and to go wherever you wished. But when you grow OLD, you will stretch out your hands, and someone else will fasten a belt around you and take you where you did NOT wish to go “….. JOHN 21: Patrick A. GRIFFITH, MD,FAAN Prof. Clinical Medicine [Ret’d] Mobile: